Abstract

Necroptosis is a lytic, inflammatory form of cell death that not only contributes to pathogen clearance but can also lead to disease pathogenesis. Necroptosis is triggered by RIPK3-mediated phosphorylation of MLKL, which is thought to initiate MLKL oligomerisation, membrane translocation and membrane rupture, although the precise mechanism is incompletely understood. Here, we show that K63-linked ubiquitin chains are attached to MLKL during necroptosis and that ubiquitylation of MLKL at K219 significantly contributes to the cytotoxic potential of phosphorylated MLKL. The K219R MLKL mutation protects animals from necroptosis-induced skin damage and renders cells resistant to pathogen-induced necroptosis. Mechanistically, we show that ubiquitylation of MLKL at K219 is required for higher-order assembly of MLKL at membranes, facilitating its rupture and necroptosis. We demonstrate that K219 ubiquitylation licenses MLKL activity to induce lytic cell death, suggesting that necroptotic clearance of pathogens as well as MLKL-dependent pathologies are influenced by the ubiquitin-signalling system.

Necroptosis is a form of cell death characterized by membrane rupture via MLKL oligomerization, although mechanistic details remain unclear. Here, the authors show that MLKL ubiquitylation of K219 facilitates high-order membrane assembly and subsequent rupture, promoting cytotoxicity.

Details

Title
Ubiquitylation of MLKL at lysine 219 positively regulates necroptosis-induced tissue injury and pathogen clearance
Author
Garcia, Laura Ramos 1   VIAFID ORCID Logo  ; Tenev Tencho 1 ; Newman, Richard 1 ; Haich, Rachel O 2   VIAFID ORCID Logo  ; Liccardi Gianmaria 3 ; Wicky, John Sidonie 1 ; Annibaldi Alessandro 4 ; Lu, Yu 5   VIAFID ORCID Logo  ; Pardo, Mercedes 5   VIAFID ORCID Logo  ; Young, Samuel N 6 ; Fitzgibbon Cheree 6 ; Fernando, Winnie 1 ; Guppy, Naomi 1 ; Kim, Hyojin 1 ; Lung-Yu, Liang 7 ; Lucet, Isabelle S 7   VIAFID ORCID Logo  ; Kueh, Andrew 6 ; Roxanis Ioannis 1 ; Gazinska Patrycja 1 ; Sims, Martin 8 ; Smyth, Tomoko 8 ; Ward, George 8 ; Bertin, John 9 ; Beal, Allison M 10 ; Geddes, Brad 10 ; Choudhary, Jyoti S 5   VIAFID ORCID Logo  ; Murphy, James M 7   VIAFID ORCID Logo  ; Aurelia Ball K 11   VIAFID ORCID Logo  ; Upton, Jason W 2   VIAFID ORCID Logo  ; Meier, Pascal 1   VIAFID ORCID Logo 

 The Institute of Cancer Research, The Breast Cancer Now Toby Robins Research Centre, London, UK (GRID:grid.18886.3f) (ISNI:0000 0001 1271 4623) 
 Auburn University, Department of Biological Sciences, Auburn, USA (GRID:grid.252546.2) (ISNI:0000 0001 2297 8753) 
 The Institute of Cancer Research, The Breast Cancer Now Toby Robins Research Centre, London, UK (GRID:grid.18886.3f) (ISNI:0000 0001 1271 4623); University of Cologne, Institute of Biochemistry I, Medical Faculty, Joseph-Stelzmann-Str. 44, Cologne, Germany (GRID:grid.6190.e) (ISNI:0000 0000 8580 3777) 
 The Institute of Cancer Research, The Breast Cancer Now Toby Robins Research Centre, London, UK (GRID:grid.18886.3f) (ISNI:0000 0001 1271 4623); Center for Molecular Medicine Cologne (CMMC), Cologne, Germany (GRID:grid.18886.3f) 
 The Institute of Cancer Research, Functional Proteomics Group, London, UK (GRID:grid.18886.3f) (ISNI:0000 0001 1271 4623) 
 Walter and Eliza Hall Institute of Medical Research, Parkville, Australia (GRID:grid.1042.7) 
 Walter and Eliza Hall Institute of Medical Research, Parkville, Australia (GRID:grid.1042.7); University of Melbourne, Department of Medical Biology, Parkville, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X) 
 Astex Pharmaceuticals, Cambridge, UK (GRID:grid.18886.3f) 
 GlaxoSmithKline, Innate Immunity Research Unit, Collegeville, USA (GRID:grid.418019.5) (ISNI:0000 0004 0393 4335); Immunology and Inflammation Research Therapeutic Area at Sanofi, Cambridge, USA (GRID:grid.418019.5) 
10  GlaxoSmithKline, Innate Immunity Research Unit, Collegeville, USA (GRID:grid.418019.5) (ISNI:0000 0004 0393 4335) 
11  Skidmore College, Department of Chemistry, Saratoga Springs, USA (GRID:grid.60094.3b) (ISNI:0000 0001 2270 6467) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2537858638
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.